|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 600 Princess Anne St. #7667 |
Address2 |
|
| City | Fredericksburg |
State | VA |
Zip Code | 22401 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401105721-12
|
||||||||
|
6. House ID# 448290001
|
||||||||
| TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Savanna Deretich |
Date | 8/4/2025 1:51:11 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Ending Chemical Abortion Act H.R. 692
Born-Alive Abortion Survivors Protection Act H.R. 21
Born-Alive Abortion Survivors Protection Act S. 6
Life at Conception Act H.R. 722
Protecting Life and Taxpayers Act H.R. 272
Defund Planned Parenthood Act H.R. 271
Womens Protection in Telehealth Act H.R 1349
Ultrasounds Saves Lives Act H.R. 797
Pregnancy Is Not an Illness Act H.R. 795
Second Chance for Moms Act H.R. H.R. 796
Parental Notification and Intervention Act H.R. 799
Dignity for Aborted Children Act H.R. 798
Title X Abortion Provider Prohibition Act H.R. 343
No Taxpayer Funding for the U.N. Population Fund H.R. 699
Protecting Life on College Campus Act H.R. 632
Protecting Life on College Campus Act S. 16
No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes H.R. 679
Abortion is Not Health Care Act S. 253
Protecting Life in Health Savings Accounts Act S. 251
Defund Planned Parenthood Act S. 203
Dignity for Aborted Children Act S. 242
Heartbeat Protection Act H.R. 682
FACE Act Repeal Act H.R. 589
Ensuring Accurate and Complete Abortion Data H.R. 627
To amend title XI of the Social Security Act to limit demonstration projects related to abortion under Medicaid and CHIP H.R. 719
To amend the Internal Revenue Code of 1986 to prohibit the treatment of certain distributions and reimbursements for certain abortions as qualified medical expenses H.R. 720
No Taxpayer Funding for Abortion S. 186
Protecting Life in Foreign Assistance S. 250
Protecting Life from Chemical Abortions Act H.R. 1525
Protecting Life and Integrity in Research Act S. 987
Respect Parents' Childcare Act H.R. 2282
Standing With Moms Act H.R. 688
Aid Accountability Act of 2025 S.1314
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA), Centers For Disease Control & Prevention (CDC), Defense - Dept of (DOD), Food & Drug Administration (FDA), Agriculture - Dept of (USDA), Administration for Children & Families (ACF), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ), Veterans Affairs - Dept of (VA), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Savanna |
Deretich |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Ending Chemical Abortion Act H.R. 692
Born-Alive Abortion Survivors Protection Act H.R. 21
Born-Alive Abortion Survivors Protection Act S. 6
Life at Conception Act H.R. 722
Protecting Life and Taxpayers Act H.R. 272
Defund Planned Parenthood Act H.R. 271
Womens Protection in Telehealth Act H.R 1349
Ultrasounds Saves Lives Act H.R. 797
Pregnancy Is Not an Illness Act H.R. 795
Second Chance for Moms Act H.R. H.R. 796
Parental Notification and Intervention Act H.R. 799
Dignity for Aborted Children Act H.R. 798
Title X Abortion Provider Prohibition Act H.R. 343
No Taxpayer Funding for the U.N. Population Fund H.R. 699
Protecting Life on College Campus Act H.R. 632
Protecting Life on College Campus Act S. 16
No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes H.R. 679
Abortion is Not Health Care Act S. 253
Protecting Life in Health Savings Accounts Act S. 251
Defund Planned Parenthood Act S. 203
Dignity for Aborted Children Act S. 242
Heartbeat Protection Act H.R. 682
FACE Act Repeal Act H.R. 589
Ensuring Accurate and Complete Abortion Data H.R. 627
To amend title XI of the Social Security Act to limit demonstration projects related to abortion under Medicaid and CHIP H.R. 719
To amend the Internal Revenue Code of 1986 to prohibit the treatment of certain distributions and reimbursements for certain abortions as qualified medical expenses H.R. 720
No Taxpayer Funding for Abortion S. 186
Protecting Life in Foreign Assistance S. 250
Protecting Life from Chemical Abortions Act H.R. 1525
Protecting Life and Integrity in Research Act S. 987
Respect Parents' Childcare Act H.R. 2282
Standing With Moms Act H.R. 688
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA), Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Federal Bureau of Investigation (FBI), Justice - Dept of (DOJ), Occupational Safety & Health Administration (OSHA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Savanna |
Deretich |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |